Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P +6 more·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 101–200 of 1,002

Neurodegenerative Diseases: Expanding the Prion Concept
Walker, Lary C., Jucker, Mathias · 2015 · Annual Review of Neuroscience
Pathological roles of α-synuclein in neurological disorders
Kostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, Hardy J. Rideout, Leonidas Stefanis · 2011 · The Lancet Neurology
Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
Gao, Hui-Ming, Zhang, Feng, Zhou, Hui, Kam, Wayneho, Wilson, Belinda, Hong, Jau-Shyong · 2011 · Environmental Health Perspectives
Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
Rostami, Jinar, Holmqvist, Staffan, Lindström, Veronica, Sigvardson, Jessica, Westermark, Gunilla T, Ingelsson, Martin, Bergström, Joakim, Roybon, Laurent, Erlandsson, Anna · 2017 · The Journal of Neuroscience
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Bae, Eun-Jin, Lee, He-Jin, Rockenstein, Edward, Ho, Dong-Hwan, Park, Eun-Bi, Yang, Na-Young, Desplats, Paula, Masliah, Eliezer, Lee, Seung-Jae · 2012 · The Journal of Neuroscience
Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature
Sairam Ramesh, Arosh S. Perera Molligoda Arachchige · 2023 · AIMS neuroscience
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Carroll Rutherford Fields, Nora Bengoa‐Vergniory, Richard Wade‐Martins · 2019 · Frontiers in Molecular Neuroscience
Alpha-synuclein oligomers: a new hope
Nora Bengoa‐Vergniory, Rosalind F. Roberts, Richard Wade‐Martins, Javier Alegre‐Abarrategui · 2017 · Acta Neuropathologica
Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Sooyeon Lee, Robert William Regenhardt, Nicholas H. McGarvey, Jacob I. Ayers, Lucia M. Notterpek, David Borchelt et al. · 2014 · Proceedings of the National Academy of Sciences
Research in motion: the enigma of Parkinson's disease pathology spread
Patrik Brundin, Jiayi Li, Janice L. Holton, Olle Lindvall, Tamás Révész · 2008 · Nature reviews. Neuroscience
Vagal neurocircuitry and its influence on gastric motility
Travagli, R. Alberto, Anselmi, Laura · 2016 · Nature Reviews Gastroenterology & Hepatology
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Goedert, Michel, Masuda-Suzukake, Masami, Falcon, Benjamin · 2017 · Brain
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
Hien Tran, Charlotte Hiu-Yan Chung, Michiyo Iba, Bin Zhang, John Q. Trojanowski, Kelvin C. Luk, Virginia M.‐Y. Lee · 2014 · Cell Reports
Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)
Johannes Brettschneider, Kelly Del Tredici, David John Irwin, Murray Grossman, John L. Robinson, Jon B. Toledo, Lubin Fang, Vivianna M. Van Deerlin, Albert Christian Ludolph, Virginia M.‐Y. Lee et al. · 2014 · Acta Neuropathologica
The future of stem cell therapies for Parkinson disease
Malin Parmar, Shane Grealish, Claire Henchcliffe · 2020 · Nature reviews. Neuroscience
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
Li, Wen, Englund, Elisabet, Widner, Håkan, Mattsson, Bengt, van Westen, Danielle, Lätt, Jimmy, Rehncrona, Stig, Brundin, Patrik, Björklund, Anders, Lindvall, Olle et al. · 2016 · Proceedings of the National Academy of Sciences
Cell-based therapies for Parkinson disease—past insights and future potential
Roger A. Barker, Janelle Drouin‐Ouellet, Malin Parmar · 2015 · Nature Reviews Neurology
Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity
Karin M. Danzer, Wolfgang Philipp Ruf, Preeti Putcha, Daniel Joyner, Tadafumi Hashimoto, Charles C. Glabe, Bradley T. Hyman, Pamela J. McLean · 2010 · The FASEB Journal
Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease
Zinovia Maria Kefalopoulou, Marios Politis, Paola P. Piccini, Niccolò Emanuele Mencacci, Kailash P. Bhatia, Marjan Jahanshahi, Håkan Widner, Stig Rehncrona, Patrik Brundin, Anders Björklund et al. · 2013 · JAMA Neurology
Prions, prionoids and protein misfolding disorders
Claudia Scheckel, Adriano Aguzzi · 2018 · Nature Reviews Genetics
Propagation of Protein Aggregation in Neurodegenerative Diseases
Jaime Vaquer‐Alicea, Marc I. Diamond · 2019 · Annual Review of Biochemistry
Cell-to-cell transmission of non-prion protein aggregates
Seung‐Jae Lee, Paula Desplats, Christina J. Sigurdson, Igor F. Tsigelny, Eliezer Masliah · 2010 · Nature Reviews Neurology
Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases
He-Jin Lee, Eun-Jin Bae, Seung‐Jae Lee · 2014 · Nature Reviews Neurology
Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology
Karin M. Danzer, Simon K. Krebs, Michael Wolff, Gerald Birk, Bastian Hengerer · 2009 · Journal of Neurochemistry
Adult Neurogenesis in Neurodegenerative Diseases: Figure 1.
Beate Winner, Jürgen Winkler · 2015 · Cold Spring Harbor Perspectives in Biology
The hallmarks of P arkinson's disease
Paul M. A. Antony, Nico J. Diederich, Rejko Krüger, Rudi Balling · 2013 · FEBS Journal
A star-PEG–heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases
Uwe Freudenberg, Andreas Hermann, Petra Birgit Welzel, Katja Stirl, Sigrid C. Schwarz, Milauscha Grimmer, Andrea Zieris, Woranan Panyanuwat, Stefan Zschoche, Dorit Meinhold et al. · 2009 · Biomaterials
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
Joseph J. Jankovic, Ira J. Goodman, Beth Safirstein, Tonya Marmon, Dale B. Schenk, Martin Koller, Wagner M. Zago, DANIEL K. NESS, Sue G. Griffith, Michael Grundman et al. · 2018 · JAMA Neurology
α‐Synuclein oligomers and clinical implications for Parkinson disease
Lorraine V. Kalia, Suneil Kumar Kalia, Pamela J. McLean, Andrés M. Lozano, Anthony Edward Lang · 2012 · Annals of Neurology
Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders
Anja Schneider, Mikael Simons · 2012 · Cell and Tissue Research
Alpha-synuclein and tau: teammates in neurodegeneration?
Simon Moussaud, Daryl R Jones, Elisabeth L. Moussaud-Lamodière, Marion Delenclos, Owen A. Ross, Pamela J. McLean · 2014 · Molecular Neurodegeneration
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee · 2019 · Neuroscience Letters
Manganese-Induced Neurotoxicity: New Insights Into the Triad of Protein Misfolding, Mitochondrial Impairment, and Neuroinflammation
Dilshan S. Harischandra, Shivani Ghaisas, Gary D. Zenitsky, Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy · 2019 · Frontiers in Neuroscience
Prion-like disorders: blurring the divide between transmissibility and infectivity
Mimi Cushman-Nick, Brian S. Johnson, Oliver D. King, Aaron D. Gitler, James Shorter · 2010 · Journal of Cell Science
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Oren A. Levy, Cristina Malagelada, Lloyd A. Greene · 2009 · APOPTOSIS
Alpha-synuclein: from secretion to dysfunction and death
Oldriska Marques, Tiago F. Outeiro · 2012 · Cell Death and Disease
Exosomes in the Pathology of Neurodegenerative Diseases
Jason A. Howitt, Andrew Francis Hill · 2016 · Journal of Biological Chemistry
Transplanted dopaminergic neurons develop PD pathologic changes: A second case report
Jeffrey H. Kordower, Yaping Chu, Robert A. Hauser, C. Warren Olanow, Thomas B. Freeman · 2008 · Movement Disorders
Are synucleinopathies prion-like disorders?
Élodie Angot, Jennifer A. Steiner, Christian Hansen, Jiayi Li, Patrik Brundin · 2010 · The Lancet Neurology
The prion hypothesis in Parkinson's disease: braak to the future
Visanji, Naomi P, Brooks, Patricia L, Hazrati, Lili-Naz, Lang, Anthony E · 2013 · Acta Neuropathologica Communications
α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading
Frida Loría, Jessica Vargas, Luc Bousset, Sylvie Syan, Audrey Salles, Ronald Melki, Chiara Zurzolo · 2017 · Acta Neuropathologica
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
Van der Perren, Anke, Gelders, Géraldine, Fenyi, Alexis, Bousset, Luc, Brito, Filipa, Peelaerts, Wouter, Van den Haute, Chris, Gentleman, Steve, Melki, Ronald, Baekelandt, Veerle · 2020 · Acta Neuropathologica
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin, Ronald Melki · 2017 · Journal of Neuroscience
Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype
Minakaki, Georgia, Menges, Stefanie, Kittel, Agnes, Emmanouilidou, Evangelia, Schaeffner, Iris, Barkovits, Katalin, Bergmann, Anna, Rockenstein, Edward, Adame, Anthony, Marxreiter, Franz et al. · 2018 · Autophagy
Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo
Angot, Elodie, Steiner, Jennifer A., Lema Tomé, Carla M., Ekström, Peter, Mattsson, Bengt, Björklund, Anders, Brundin, Patrik · 2012 · PLoS ONE
Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Kazuhiro Fujita, Marek Ostaszewski, Yukiko Matsuoka, Samik Ghosh, Enrico Glaab, Christophe Trefois, Isaac Crespo, Thanneer Malai Perumal, Wiktor Jurkowski, Paul M. A. Antony et al. · 2013 · Molecular Neurobiology
Genetic Analysis of Pathways to Parkinson Disease
John Hardy · 2010 · Neuron
Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
Maria José Diógenes, Raquel B. Dias, Diogo M. Rombo, Hugo Vicente Miranda, Francesca Maiolino, Patrícia Silva Guerreiro, Thomas Näsström, Henri G. Franquelim, Luís M. A. Oliveira, Miguel A. R. B. Castanho et al. · 2012 · Journal of Neuroscience
The neuropathology, pathophysiology and genetics of multiple system atrophy
Zeshan Ahmed, Yasmine T. Asi, Anna Sailer, Andrew John Lees, Henry Houlden, Tamás Révész, Janice L. Holton · 2011 · Neuropathology and Applied Neurobiology
The ongoing pursuit of neuroprotective therapies in Parkinson disease
Dilan S. Athauda, Thomas Foltynie · 2014 · Nature Reviews Neurology
Initiation and propagation of α-synuclein aggregation in the nervous system
Baraa A. Hijaz, Laura A. Volpicelli‐Daley · 2020 · Molecular Neurodegeneration
Is Parkinson's disease a prion disorder?
C. Warren Olanow, Stanley B. Prusiner · 2009 · Proceedings of the National Academy of Sciences
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira · 2022 · Cells
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
Ramachandiran Nandhagopal, Lisa Kuramoto, Michael Schulzer, Edwin Mak, Jacquelyn J. Cragg, C. S. Lee, Jess McKenzie, Siobhan McCormick, Ali Samii, André R. Troiano et al. · 2009 · Brain
The second brain and Parkinson’s disease
Thibaud Lebouvier, Tanguy Chaumette, Sébastien Paillusson, Charles J. Duyckaerts, Stanislas Bruley des Varannes, Michel Neunlist, Pascal Derkinderen · 2009 · European Journal of Neuroscience
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, Nolwen L., Wesson, Daniel W., Brundin, Patrik · 2018 · Neurobiology of Disease
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins
William P. Flavin, Luc Bousset, Zachary C. Green, Yaping Chu, Stratos Skarpathiotis, Michael J. Chaney, Jeffrey H. Kordower, Ronald Melki, Edward M. Campbell · 2017 · Acta Neuropathologica
Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission
Moreno-Gonzalez, Ines, Soto, Claudio · 2011 · Seminars in Cell & Developmental Biology
Neurobiology and treatment of Parkinson's disease
Anthony H.V. Schapira · 2008 · Trends in Pharmacological Sciences
Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo
Porta, Sílvia, Xu, Yan, Restrepo, Clark R., Kwong, Linda K., Zhang, Bin, Brown, Hannah J., Lee, Edward B., Trojanowski, John Q., Lee, Virginia M.-Y. · 2018 · Nature Communications
First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk, Martin Koller, DANIEL K. NESS, Sue G. Griffith, Michael Grundman, Wagner M. Zago, Jay Soto, George J. Atiee, Susanne Ostrowitzki, Gene G. Kinney · 2016 · Movement Disorders
Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?
Vignayanandam Ravindernath Muddapu, S. Akila Parvathy Dharshini, V. Srinivasa Chakravarthy, M. Michael Gromiha · 2020 · Frontiers in Neuroscience
Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the Cells
Laura Pieri, Karine Madiona, Luc Bousset, Ronald Melki · 2012 · Biophysical Journal
The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
Matthew J. Benskey, Ruth G. Perez, Fredric P. Manfredsson · 2016 · Journal of Neurochemistry
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
Yoland Smith, Thomas Wichmann, Stewart Alan Factor, Mahlon R. DeLong · 2011 · Neuropsychopharmacology
The Role of α-Synuclein Oligomers in Parkinson’s Disease
Xiao-yu Du, Xi-xiu Xie, Rui‐tian Liu · 2020 · International Journal of Molecular Sciences
Propagation of prions causing synucleinopathies in cultured cells
Amanda L. Woerman, Jan Stöhr, Atsushi Aoyagi, Ryan Rampersaud, Zuzana Krejciova, Joel C. Watts, Takao Ohyama, Smita S. Patel, Kartika Widjaja, Abby Oehler et al. · 2015 · Proceedings of the National Academy of Sciences
Brain Regeneration in Physiology and Pathology: The Immune Signature Driving Therapeutic Plasticity of Neural Stem Cells
Gianvito Martino, Stefano Pluchino, Luca Bonfanti, Michal Schwartz · 2011 · Physiological Reviews
CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges
Simon Hornung, Suman Dutta, Gal Bitan · 2020 · Frontiers in Molecular Neuroscience
Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
Carla M. Lema Tomé, Trevor Tyson, Nolwen L. Rey, Stefan A. Grathwohl, Markus Britschgi, Patrik Brundin · 2012 · Molecular Neurobiology
Parkinson's Disease Genetics and Pathophysiology
Gabriel E. Vázquez-Vélez, Huda Yahya Zoghbi · 2021 · Annual Review of Neuroscience
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes
Stephanie M.Y. Kong, Brian K.K. Chan, Jin‐Sung Park, Kathryn J. Hill, Jade B. Aitken, Louise Cottle, Hovik Farghaian, Adam R. Cole, Peter A. Lay, Carolyn M. Sue et al. · 2014 · Human Molecular Genetics
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease
Nobukatsu Sawamoto, Daisuke Doi, Etsuro Nakanishi, Masanori Sawamura, Takayuki Kikuchi, Hodaka Yamakado, Yosuke Taruno, Atsushi Shima, Yasutaka Fushimi, Tomohisa Okada et al. · 2025 · Nature
Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
George, Sonia, Rey, Nolwen L., Tyson, Trevor, Esquibel, Corinne, Meyerdirk, Lindsay, Schulz, Emily, Pierce, Steven, Burmeister, Amanda R., Madaj, Zachary, Steiner, Jennifer A. et al. · 2019 · Molecular Neurodegeneration
A critical reappraisal of current staging of Lewy-related pathology in human brain
K. A. Jellinger · 2008 · Acta Neuropathologica
Design and construction of diverse mammalian prion strains
David W. Colby, Kurt Giles, Giuseppe Legname, Holger Wille, Ilia V. Baskakov, Stephen J. DeArmond, Stanley B. Prusiner · 2009 · Proceedings of the National Academy of Sciences
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
K. A. Jellinger · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
Grassi, Diego, Howard, Shannon, Zhou, Minghai, Diaz-Perez, Natalia, Urban, Nicolai T., Guerrero-Given, Debbie, Kamasawa, Naomi, Volpicelli-Daley, Laura A., LoGrasso, Philip, Lasmézas, Corinne Ida · 2018 · Proceedings of the National Academy of Sciences
Astrocytes and Therapeutics for Parkinson's Disease
Phillip M. Rappold, Kim Tieu · 2010 · Neurotherapeutics
Developing Therapeutic Antibodies for Neurodegenerative Disease
Y. Joy Yu, Ryan J. Watts · 2013 · Neurotherapeutics
CD15, CD24, and CD29 Define a Surface Biomarker Code for Neural Lineage Differentiation of Stem Cells
Jan Pruszak, Wesley W. Ludwig, Alexandra A. Blak, Kambiz N. Alavian, Ole Isacson A · 2009 · Stem Cells
Modeling Parkinson’s Disease in C. elegans
Jason F. Cooper, Jeremy M. Van Raamsdonk · 2018 · Journal of Parkinson s Disease
Alpha-Synuclein Function and Dysfunction on Cellular Membranes
David Snead, David Eliezer · 2014 · Experimental Neurobiology
Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
Sara Almeida Ferreira, Marina Romero‐Ramos · 2018 · Frontiers in Cellular Neuroscience
Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading
Marija Iljina, Gonzalo A. Garcia, Mathew H. Horrocks, Laura Tosatto, Minee L. Choi, Kristina A. Ganzinger, Andrey Y. Abramov, Sonia Gandhi, Nicholas William Wood, Nunilo Cremades et al. · 2016 · Proceedings of the National Academy of Sciences
New approaches for brain repair-from rescue to reprogramming
Barker, Roger A., Götz, Magdalena, Parmar, Malin · 2018 · Nature
Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
Lars Brichta, Paul Greengard · 2014 · Frontiers in Neuroanatomy
Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
Jiayi Li, Elisabet M. Englund, Håkan Widner, Stig Rehncrona, Anders Björklund, Olle Lindvall, Patrik Brundin · 2010 · Movement Disorders
Cross‐seeding effects of amyloid β‐protein and α‐synuclein
Kenjiro Ono, Ryoichi Takahashi, Tokuhei Ikeda, Masahito Yamada · 2012 · Journal of Neurochemistry
The role of extracellular vesicles in neurodegenerative diseases
Quek, Camelia, Hill, Andrew F. · 2017 · Biochemical and Biophysical Research Communications
Parkinson’s disease and multiple system atrophy have distinct α-synuclein seed characteristics
Tritia R. Yamasaki, Brandon B. Holmes, Jennifer L. Furman, Dhruva D. Dhavale, Bryant W. Su, Eun-Suk Song, Nigel J. Cairns, Paul T. Kotzbauer, Marc I. Diamond · 2018 · Journal of Biological Chemistry
Transmissible Proteins: Expanding the Prion Heresy
Claudio A. Soto · 2012 · Cell
Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology
María Izco, Javier Blesa, Martin Schleef, Marco Schmeer, Riccardo Porcari, Raya Al‐Shawi, Stéphan Ellmerich, María de Toro, Chris Gardiner, Yiqi Seow et al. · 2019 · Molecular Therapy
Microglia as modulators of exosomal alpha-synuclein transmission
Yun Fei Xia, Guoxin Zhang, Chao Han, Kai Ma, Xingfang Guo, Fang Jung Wan, Liang Kou, Sijia Yin, Ling Liu, Jinsha Huang et al. · 2019 · Cell Death and Disease
Extracellular vesicles – Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases
Coleman, Bradley M., Hill, Andrew F. · 2015 · Seminars in Cell & Developmental Biology
α‐synuclein assemblies sequester neuronal α3‐Na+/K+‐ATPase and impair Na+ gradient
Amulya Nidhi Shrivastava, Virginie Redeker, Nicolas Fritz, Laura Pieri, Leandro G. Almeida, Maria Spolidoro, Thomas Liebmann, Luc Bousset, Marianne L. Renner, Clément Léna et al. · 2015 · The EMBO Journal
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, Paula, Kliest, Tessa, Dodiya, Hemraj B., Broersen, Laus M., Garssen, Johan, Keshavarzian, Ali, Kraneveld, Aletta D. · 2017 · European Journal of Pharmacology
Parkinson's disease and α‐synuclein expression
Michael J. Devine, Katrina A. Gwinn, Andrew Singleton, John Hardy · 2011 · Movement Disorders
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking
Steven A. Goldman · 2016 · Cell stem cell
Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
Holmes, Brandon B., Diamond, Marc I. · 2014 · Journal of Biological Chemistry